Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years

Podobne knjige/članki

• Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 Studies
  od: Julien Seneschal, et al.
  Izdano: (2025-03-01)
• Psychometric Evaluation of the Facial and Total Vitiligo Area Scoring Index Instruments in the TRuE-V Phase 3 Studies
  od: Kristen Bibeau, et al.
  Izdano: (2024-07-01)
• Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years
  od: John E. Harris, et al.
  Izdano: (2024-12-01)
• Long-Term Integrated Safety Summary of Ruxolitinib Cream in Phase 3 Clinical Trials of Patients with Vitiligo
  od: David Rosmarin, et al.
  Izdano: (2025-10-01)
• TruNeo: an integrated pipeline improves personalized true tumor neoantigen identification
  od: Yunxia Tang, et al.
  Izdano: (2020-11-01)